ID

39564

Description

A Two-year Study of Telbivudine in HBeAg Negative Hepatitis; ODM derived from: https://clinicaltrials.gov/show/NCT01521975

Link

https://clinicaltrials.gov/show/NCT01521975

Keywords

Versions (2)
  1. 1/29/20 1/29/20 -
  2. 9/20/21 9/20/21 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

January 29, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hepatitis B, Chronic NCT01521975

English

Eligibility Hepatitis B, Chronic NCT01521975

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
detectable serum hbsag at the screening visit and at least 6 months prior
Description

Serum Hepatitis B Surface Antigens Detectable

Data type

boolean

Alias
UMLS CUI [1,1]
C0229671
UMLS CUI [1,2]
C0019168
UMLS CUI [1,3]
C3830527
hbeag negative at screening visit
Description

Hepatitis B e Antigens Negative

Data type

boolean

Alias
UMLS CUI [1,1]
C0019167
UMLS CUI [1,2]
C1513916
serum hbv dna level >2,000 iu/ml at screening visit
Description

Serum Hepatitis B DNA Measurement

Data type

boolean

Alias
UMLS CUI [1,1]
C0229671
UMLS CUI [1,2]
C3641250
elevated serum alt≥2 ×uln and <10×uln at screening visit (excluding alt elevations due to non-hbv reasons such as drug, alcohol etc)
Description

Elevated serum alanine aminotransferase (ALT)

Data type

boolean

Alias
UMLS CUI [1]
C4313265
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patient has a history of clinical signs/symptoms of hepatic decompensation (child-pugh grade b or c) or ascites, esophageal variceal bleeding, hepatic encephalopathy, or spontaneous bacterial peritonitis.
Description

Sign or Symptom Hepatic decompensation | Child-Pugh Classification | Ascites | Bleeding esophageal varices | Hepatic Encephalopathy | Primary bacterial peritonitis

Data type

boolean

Alias
UMLS CUI [1,1]
C3540840
UMLS CUI [1,2]
C1394798
UMLS CUI [2]
C2347612
UMLS CUI [3]
C0003962
UMLS CUI [4]
C0155789
UMLS CUI [5]
C0019151
UMLS CUI [6]
C0275551
patient has a history of hepatocellular carcinoma (hcc) or suspected symptoms of hcc, such as suspicious foci on imaging studies and/or serum alpha-fetoprotein (afp)>50ng/ml.
Description

Liver carcinoma | Symptoms Suspected Liver carcinoma | Foci Suspicious Imaging studies | Serum alpha-fetoprotein (AFP) measurement

Data type

boolean

Alias
UMLS CUI [1]
C2239176
UMLS CUI [2,1]
C1457887
UMLS CUI [2,2]
C0750491
UMLS CUI [2,3]
C2239176
UMLS CUI [3,1]
C4321394
UMLS CUI [3,2]
C0750493
UMLS CUI [3,3]
C1881134
UMLS CUI [4]
C0546833
patient has received treatment of nucleoside or nucleotide drugs whether approved or investigational before.
Description

Nucleosides | Nucleotides | Nucleosides Investigational | Nucleotides Investigational

Data type

boolean

Alias
UMLS CUI [1]
C0028621
UMLS CUI [2]
C0028630
UMLS CUI [3,1]
C0028621
UMLS CUI [3,2]
C1517586
UMLS CUI [4,1]
C0028630
UMLS CUI [4,2]
C1517586
patient has received ifn or other immunomodulatory treatment within 52 weeks before screening.
Description

Interferon | Immunomodulatory therapy

Data type

boolean

Alias
UMLS CUI [1]
C0021747
UMLS CUI [2]
C1963758
patient has a medical condition that requires frequent use of systemic acyclovir or famciclovir.
Description

Medical condition Requirement Acyclovir | Acyclovir Systemic Frequent | Medical condition Requirement Famciclovir | Famciclovir Systemic Frequent

Data type

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0001367
UMLS CUI [2,1]
C0001367
UMLS CUI [2,2]
C0205373
UMLS CUI [2,3]
C0332183
UMLS CUI [3,1]
C3843040
UMLS CUI [3,2]
C1514873
UMLS CUI [3,3]
C0209227
UMLS CUI [4,1]
C0209227
UMLS CUI [4,2]
C0205373
UMLS CUI [4,3]
C0332183
patient has a medical condition that requires frequent use of systemic corticosteroids, however topical and inhaled corticosteroids are allowed.
Description

Medical condition Requirement CORTICOSTEROIDS FOR SYSTEMIC USE Frequent | Topical corticosteroids allowed | Adrenal Cortex Hormones By inhalation allowed

Data type

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C3653708
UMLS CUI [1,4]
C0332183
UMLS CUI [2,1]
C0304604
UMLS CUI [2,2]
C0683607
UMLS CUI [3,1]
C0001617
UMLS CUI [3,2]
C0205535
UMLS CUI [3,3]
C0683607
patient has used hepatotoxic drugs within one month.
Description

Pharmaceutical Preparations Hepatotoxic effect

Data type

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0235378
patient has overtaken alcohol (>40g/day) or abused illicit drugs in recent one year.
Description

Heavy alcohol consumption | DRUG ABUSE ILLICIT

Data type

boolean

Alias
UMLS CUI [1]
C2030272
UMLS CUI [2]
C0743253
use of other investigational drugs at the time of enrollment.
Description

Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0013230
history of hypersensitivity to any of the study drugs (telbivudine or adefovir).
Description

Hypersensitivity Investigational New Drugs | Hypersensitivity Telbivudine | Hypersensitivity Adefovir

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C1453933
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0050175
pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive urine pregnancy test.
Description

Pregnancy | Urine pregnancy test positive | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0430059
UMLS CUI [3]
C0006147
patient is co-infected with hcv, hdv or hiv.
Description

HCV coinfection | Coinfection Hepatitis Delta Virus | HIV coinfection

Data type

boolean

Alias
UMLS CUI [1]
C1698259
UMLS CUI [2,1]
C0275524
UMLS CUI [2,2]
C0011220
UMLS CUI [3]
C4062778
patient has one or more additional known primary or secondary causes of liver disease, other than hepatitis b (e.g., alcoholism, autoimmune hepatitis).
Description

Cause Additional Liver disease | Cause Primary Quantity | Cause Secondary Quantity | Exception Hepatitis B | Alcoholic Intoxication, Chronic | Hepatitis, Autoimmune

Data type

boolean

Alias
UMLS CUI [1,1]
C0015127
UMLS CUI [1,2]
C1524062
UMLS CUI [1,3]
C0023895
UMLS CUI [2,1]
C0015127
UMLS CUI [2,2]
C0205225
UMLS CUI [2,3]
C1265611
UMLS CUI [3,1]
C0015127
UMLS CUI [3,2]
C0175668
UMLS CUI [3,3]
C1265611
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0019163
UMLS CUI [5]
C0001973
UMLS CUI [6]
C0241910
history of malignancy of any organ system.
Description

Malignant Neoplasm Organ system Any

Data type

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0460002
UMLS CUI [1,3]
C1552551
Back to the top of the page

Similar models

Eligibility Hepatitis B, Chronic NCT01521975

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Serum Hepatitis B Surface Antigens Detectable
Item
detectable serum hbsag at the screening visit and at least 6 months prior
boolean
C0229671 (UMLS CUI [1,1])
C0019168 (UMLS CUI [1,2])
C3830527 (UMLS CUI [1,3])
Hepatitis B e Antigens Negative
Item
hbeag negative at screening visit
boolean
C0019167 (UMLS CUI [1,1])
C1513916 (UMLS CUI [1,2])
Serum Hepatitis B DNA Measurement
Item
serum hbv dna level >2,000 iu/ml at screening visit
boolean
C0229671 (UMLS CUI [1,1])
C3641250 (UMLS CUI [1,2])
Elevated serum alanine aminotransferase (ALT)
Item
elevated serum alt≥2 ×uln and <10×uln at screening visit (excluding alt elevations due to non-hbv reasons such as drug, alcohol etc)
boolean
C4313265 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Sign or Symptom Hepatic decompensation | Child-Pugh Classification | Ascites | Bleeding esophageal varices | Hepatic Encephalopathy | Primary bacterial peritonitis
Item
patient has a history of clinical signs/symptoms of hepatic decompensation (child-pugh grade b or c) or ascites, esophageal variceal bleeding, hepatic encephalopathy, or spontaneous bacterial peritonitis.
boolean
C3540840 (UMLS CUI [1,1])
C1394798 (UMLS CUI [1,2])
C2347612 (UMLS CUI [2])
C0003962 (UMLS CUI [3])
C0155789 (UMLS CUI [4])
C0019151 (UMLS CUI [5])
C0275551 (UMLS CUI [6])
Liver carcinoma | Symptoms Suspected Liver carcinoma | Foci Suspicious Imaging studies | Serum alpha-fetoprotein (AFP) measurement
Item
patient has a history of hepatocellular carcinoma (hcc) or suspected symptoms of hcc, such as suspicious foci on imaging studies and/or serum alpha-fetoprotein (afp)>50ng/ml.
boolean
C2239176 (UMLS CUI [1])
C1457887 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
C2239176 (UMLS CUI [2,3])
C4321394 (UMLS CUI [3,1])
C0750493 (UMLS CUI [3,2])
C1881134 (UMLS CUI [3,3])
C0546833 (UMLS CUI [4])
Nucleosides | Nucleotides | Nucleosides Investigational | Nucleotides Investigational
Item
patient has received treatment of nucleoside or nucleotide drugs whether approved or investigational before.
boolean
C0028621 (UMLS CUI [1])
C0028630 (UMLS CUI [2])
C0028621 (UMLS CUI [3,1])
C1517586 (UMLS CUI [3,2])
C0028630 (UMLS CUI [4,1])
C1517586 (UMLS CUI [4,2])
Interferon | Immunomodulatory therapy
Item
patient has received ifn or other immunomodulatory treatment within 52 weeks before screening.
boolean
C0021747 (UMLS CUI [1])
C1963758 (UMLS CUI [2])
Medical condition Requirement Acyclovir | Acyclovir Systemic Frequent | Medical condition Requirement Famciclovir | Famciclovir Systemic Frequent
Item
patient has a medical condition that requires frequent use of systemic acyclovir or famciclovir.
boolean
C3843040 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0001367 (UMLS CUI [1,3])
C0001367 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C0332183 (UMLS CUI [2,3])
C3843040 (UMLS CUI [3,1])
C1514873 (UMLS CUI [3,2])
C0209227 (UMLS CUI [3,3])
C0209227 (UMLS CUI [4,1])
C0205373 (UMLS CUI [4,2])
C0332183 (UMLS CUI [4,3])
Medical condition Requirement CORTICOSTEROIDS FOR SYSTEMIC USE Frequent | Topical corticosteroids allowed | Adrenal Cortex Hormones By inhalation allowed
Item
patient has a medical condition that requires frequent use of systemic corticosteroids, however topical and inhaled corticosteroids are allowed.
boolean
C3843040 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C3653708 (UMLS CUI [1,3])
C0332183 (UMLS CUI [1,4])
C0304604 (UMLS CUI [2,1])
C0683607 (UMLS CUI [2,2])
C0001617 (UMLS CUI [3,1])
C0205535 (UMLS CUI [3,2])
C0683607 (UMLS CUI [3,3])
Pharmaceutical Preparations Hepatotoxic effect
Item
patient has used hepatotoxic drugs within one month.
boolean
C0013227 (UMLS CUI [1,1])
C0235378 (UMLS CUI [1,2])
Heavy alcohol consumption | DRUG ABUSE ILLICIT
Item
patient has overtaken alcohol (>40g/day) or abused illicit drugs in recent one year.
boolean
C2030272 (UMLS CUI [1])
C0743253 (UMLS CUI [2])
Investigational New Drugs
Item
use of other investigational drugs at the time of enrollment.
boolean
C0013230 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs | Hypersensitivity Telbivudine | Hypersensitivity Adefovir
Item
history of hypersensitivity to any of the study drugs (telbivudine or adefovir).
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C1453933 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0050175 (UMLS CUI [3,2])
Pregnancy | Urine pregnancy test positive | Breast Feeding
Item
pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive urine pregnancy test.
boolean
C0032961 (UMLS CUI [1])
C0430059 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
HCV coinfection | Coinfection Hepatitis Delta Virus | HIV coinfection
Item
patient is co-infected with hcv, hdv or hiv.
boolean
C1698259 (UMLS CUI [1])
C0275524 (UMLS CUI [2,1])
C0011220 (UMLS CUI [2,2])
C4062778 (UMLS CUI [3])
Cause Additional Liver disease | Cause Primary Quantity | Cause Secondary Quantity | Exception Hepatitis B | Alcoholic Intoxication, Chronic | Hepatitis, Autoimmune
Item
patient has one or more additional known primary or secondary causes of liver disease, other than hepatitis b (e.g., alcoholism, autoimmune hepatitis).
boolean
C0015127 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
C0023895 (UMLS CUI [1,3])
C0015127 (UMLS CUI [2,1])
C0205225 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C0015127 (UMLS CUI [3,1])
C0175668 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0019163 (UMLS CUI [4,2])
C0001973 (UMLS CUI [5])
C0241910 (UMLS CUI [6])
Malignant Neoplasm Organ system Any
Item
history of malignancy of any organ system.
boolean
C0006826 (UMLS CUI [1,1])
C0460002 (UMLS CUI [1,2])
C1552551 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial